Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Sep 10.
Published in final edited form as: Free Radic Biol Med. 2009 Oct 12;48(2):189–195. doi: 10.1016/j.freeradbiomed.2009.10.027

pO2 Dependent NO Production Determines OPPC Activity in Macrophages

Mary A Robinson 1, Stephen W Turtle 1, Cynthia M Otto 2,3, Cameron J Koch 1
PMCID: PMC4159751  NIHMSID: NIHMS165834  PMID: 19822207

Abstract

Stimulated macrophages produce nitric oxide (NO) via inducible nitric oxide synthase (iNOS) using molecular O2, L-arginine, and NADPH. Exposure of macrophages to hypoxia decreases NO production within seconds suggesting substrate limitation as the mechanism. Conflicting data exist regarding the effect of pO2 on NADPH production via the oxidative pentose phosphate cycle (OPPC). Therefore, the present studies were developed to determine whether NADPH could be limiting for NO production under hypoxia. Production of NO metabolites (NOx) and OPPC activity by RAW 264.7 cells was significantly increased by stimulation with lipopolysaccharide (LPS) and interferon γ (IFNγ) at pO2 ranging from 0.07% to 50%. OPPC activity correlated linearly with NOx production at pO2 > 0.13%. Increased OPPC activity by stimulated RAW 264.7 cells was significantly reduced by 1400W, an iNOS inhibitor. OPPC activity was significantly increased by concomitant treatment of stimulated RAW 264.7 cells with chemical oxidants such as hydroxy-ethyldisulfide or pimonidazole, at 0.07% and 50% O2, without decreasing NOx production. These results are the first to investigate the effect of pO2 on the relationship between NO production and OPPC activity, and to rule out limitations in OPPC activity as a mechanism by which NO production is decreased under hypoxia.

Keywords: NADPH, reactive nitrogen mediated stress, oxidative stress, inflammation

INTRODUCTION

Nitric oxide (NO) production is a key component of the macrophage response during inflammation (1, 2). Macrophages stimulated by pathogen associated molecular patterns (PAMPs) produce NO from molecular O2, L-arginine, and NADPH via inducible nitric oxide synthase (iNOS) (3). NO production clearly depends on the partial pressure of O2 (pO2) (46), and the estimated cellular KmO2 (14 Torr (4) to 77 Torr (5)) is within the physiological range (5 to 71 Torr (713)). Systemic and/or tissue hypoxia develops during several inflammatory diseases (10, 14, 15), extending the pO2 range for tissue macrophages to even lower levels, and potentially limiting NO production in vivo. Acute exposures to hypoxia have been shown to rapidly (within seconds) and reversibly decrease NO production by PAMPs stimulated macrophages without decreasing iNOS protein or assembly (6), providing evidence for the dynamic regulation of NO production by substrate limitation. While molecular O2 is clearly limiting, an effect of hypoxia on the electron donor NADPH represents a second potential mechanism that has not been investigated in macrophages.

NADPH is constitutively produced by NADP+ dependent malic enzyme and isocitrate dehydrogenase. When oxidative stress is low, the ratio of NADPH:NADP+ is greater than 100:1. These enzymes do not have the capacity to maintain this high ratio under conditions of oxidative stress. Increased [NADP+] activates glucose-6-phosphate dehydrogenase (G6PD), the initial and rate limiting enzyme of the oxidative pentose phosphate cycle (OPPC) (16). Studies using G6PD mutants have demonstrated the unique role of the OPPC in maintaining adequate bioreducing reserves (17).

An association between NADPH production by G6PD and the production of NO has previously been demonstrated in endothelial cells (1820), an insulin-producing pancreatic beta cell line (RINm5F) (21), and macrophages (2225). In macrophages, stimulation with PAMPs was found to elicit a parallel increase in OPPC activity (2628) and NO production (25), by increasing G6PD activity and metabolic flux through the OPPC, rather than via the malic enzyme (29). Moreover, pharmacologic inhibition of OPPC activity or G6PD deficiency was shown to significantly impair NO production by stimulated macrophages (2224).

Reduction of NADP+ via the OPPC does not require molecular O2. Classical studies have measured increased [NADPH] in response to short term hypoxia due to the absence of metabolically-generated oxidizing agents (3033). More recently, however, [NADPH] was found to be significantly decreased in denuded bovine coronary arteries following brief exposure to hypoxia (~ 8 to 10 Torr, 20 minutes (34)). This effect was attributed to increased glycolytic flux, resulting in the redirection of substrate (glucose-6-phosphate) away from the OPPC. However, OPPC activity was not directly measured in these experiments. These results suggest NADPH availability may be limited during acute hypoxia in some tissues and/or cell types.

The primary goal of this study was to investigate the relationship between pO2 (0.07% to 50%), NO production, and OPPC activity in PAMPs stimulated and unstimulated macrophages. We chose to study RAW 264.7 cells due to the extensive literature on the pO2 dependence of NO production in these cells (46), and due to their abundant and persistent NO production (35). First, we hypothesized that 4 hours of hypoxia would decrease NO production and OPPC activity without affecting iNOS concentration or iNOS dimerization. Second, we hypothesized that pO2 would not limit the response of OPPC activity. To test this, we imposed additional oxidative stress by adding the chemicals hydroxyethyldisulfide (HEDS) or pimonidazole. These two compounds have substantially different modes of action. HEDS is reduced through thiol-disulfide reactions ultimately linked to maintenance of reduced glutathione (3638), whereas pimonidazole (a 2-nitroimidazole) is reduced via the cytochrome p450 system (17). We found that these additions increased the flux of the OPPC, but did not modify NOx production. Thus, our results suggest that pO2, and not NADPH availability, affects NO production by PAMPs stimulated macrophages during acute hypoxia.

METHODS

Cell Culture

RAW 264.7 cells (American Type Culture Collection, Manassas, VA) were maintained at 37°C 5% CO2 in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (HyClone, Logan, Utah) and 1% antibiotic/antimycotic (penicillin, streptamycin, amphotericin B; Invitrogen) for up to 10 passages. Glass dishes and vials were cleaned and baked at 420°C, then treated with 75 mM sodium carbonate (Fisher, Fair Lawn, NJ) and 15% FBS for 1 hour at 37°C, treated with 0.2% gelatin (BioRad, Richmond, CA) for 20 minutes, and dried under UV light prior to plating the cells. For experiments, 106 cells were plated onto 20 mL glass vials (inner diameter ~ 24 mm), or 1.5 × 106 cells were plated onto the center of 50 mm glass dishes (39). Cells were then cultured overnight with 3 mL of MEM (Invitrogen, 11095) supplemented with penicillin, streptomycin, 15% FBS, non-essential amino acids, and 1 mM pyruvate. Stimulation of RAW 264.7 cells was performed by treating cells overnight (at least 18 hours) with 1 µg/ mL LPS (E. coli O111:B4; Sigma) and 100 U/mL CHO-derived recombinant mouse IFNγ (Cell Sciences, Canton, MA). Immediately prior to experiments, the media was replaced with 1 mL of low glucose (2 mM) MEM buffered with 25 mM HEPES (i.e. instead of sodium bicarbonate to prevent saturation of the filter paper with unlabeled CO2 during the measurement) and containing 5% FBS, non-essential amino acids, 1% penicillin and streptomycin, and 2 mM glutamine. The glucose was labeled with 14C at either the C1 or C6 position in order to quantify oxidation by either the TCA or OPPC (see below). HEPES-buffered media pH was not affected by pO2 or any of the other treatment conditions (data not shown). Where indicated, NOx production was inhibited by treating cells with 100 µM N-[[3-(aminomethyl)phenyl]methyl]-ethanimidamide, dihydrochloride (1400W; Cayman Chemical, Ann Arbor, MI) in the absence of L-arginine for 1 ½ hours immediately prior to switching to low glucose media. To chemically induce oxidative stress, 2 mM hydroxyethyldisulfide (HEDS) or 2 mM pimonidazole (PIMO) were added to the low glucose media.

pO2 Control with ‘Thin Film’ Cell Culture

RAW 264.7 cells were cultured at 0.07%, 0.13%, 0.24%, 0.61%, 2%, 10%, or 50% O2 for 4 hours at 37°C in vials or dishes contained in leak proof aluminum chambers, which enabled precise control of headspace pO2 as previously described (31, 3941). Briefly, glass vials were capped with a rubber stopper containing a center well (Kimble Chase, Vineland, NJ) with a 1 × 0.5 cm Whatman GF/B glass-fiber filter soaked with 100 µL 5% KOH (31). A 25G 5/8 inch needle was inserted into the stopper to enable slow gas exchange during the evacuations and pressurizations for oxygen control, while limiting gas exchange under the constant pressure conditions during the subsequent incubation (31). Vials or dishes were placed in aluminum chambers and subjected to a series of gas exchanges with N2 or O2 to produce the desired headspace pO2. Chambers were warmed to 37°C and shaken continuously (64 cycles per minute) to ensure adequate gas exchange between the headspace and the media throughout the experiment (4 hours). The pO2 in the chambers was measured at the end of the incubation period using a polarographic oxygen electrode. However, the pO2 in the headspace of each vial was not directly accessible. Additionally, the depth of the medium layer in the vials did not conform to the “thin-layer” model that was originally developed in 50 mm glass dishes (39). Thus, in separate experiments, we added 100 µM EF5 to both dishes and vials, and assayed for EF5 adducts using flow cytometry as previously described (40, 42) in order to directly assess cellular pO2. Note that in the experiments presented, pO2 is defined as the percentage of oxygen in 1 atmosphere of dry gas at 37°C (i.e. 100% = 760 mm of Hg).

NOx Measurement

Nitrite, nitrate, and nitrosothiols (NOx) were measured in media or cell lysates by injecting 20 µL of sample into a reaction chamber containing a VCl3/HCl mixture (0.4 g VCl3 in 50 mL 1 N HCl) heated to 90°C. The resulting NO was continuously flushed with helium into a Sievers Nitric Oxide Analyzer 280i (GE Analytical Instruments, Boulder, CO) for reaction with ozone and measurement via chemiluminescence. Quantification was performed by comparison to standards prepared with NaNO2.

Electrophoresis and Immunoblotting

Cell lysates were prepared by washing cell monolayers with ice cold cell rinse (6.8 g/L NaCl, 400 mg/L KCl, 122 mg/L NaH2PO4 anhydrous, 1 g/L glucose, 25 mM HEPES, pH 7.2), and then scraping cells into 0.4 mL ice cold protease-inhibitor containing hypotonic lysis buffer (1:1000 Protease Inhibitor Cocktail P8340 (Sigma-Aldrich, St. Louis, MO), 10 µM phenylmethylsulfonyl fluoride (Sigma-Aldrich) in dH2O). Lysates were subjected to 3 freeze/thaw cycles (−70°C to 25°C). Cell lysate protein concentration was measured using the Biorad DC protein assay (Hercules, CA). Proteins (5 µg) were separated on a 7.5% Tris-HCl gel using SDS PAGE or low temperature SDS PAGE (LT SDS PAGE) as previously described (6), transferred to polyvinylidene fluoride (Immobilon™-FL 0.45 µm; Millipore, Bedford, MA), and immunoblotted for iNOS (1:2000; NOS2 M19 sc650, Santa Cruz Biotechnology, Inc., Santa Cruz, CA). β actin (1:20,000; Monoclonal anti-β actin Clone AC-15 A5441, Sigma-Aldrich) was used as the loading control. Primary antibodies were immunocomplexed with IRDye™ 800 goat anti-rabbit or goat anti-mouse (1:10,000; Rockland, Gilbertsville, PA). Proteins were detected, documented, and analyzed using an Odyssey Imaging System and software (LiCor Biosciences, Lincoln, NE).

OPPC and TCA Activity

OPPC activity and TCA activity were measured as previously described (Figure 1 and Supplemental Figure 1 in reference 31). RAW 264.7 cells were cultured in the presence of 2 mM glucose labeled with 14C at either the C1 or C6 position at a specific activity of 200 µCi/mmol glucose in 1 ml of bicarbonate-free MEM. At the completion of each experiment, the vials were removed from the aluminum chambers, the needle was removed from the rubber stopper, and cellular metabolism was stopped by injection of 100 µL 6 N acetic acid into the media; the acidification step also releases CO2 from the medium into the gas phase. 14CO2 was collected on a 5% KOH saturated filter overnight at room temperature. The filter was removed and the 14CO2 was counted with a Packard liquid scintillation counter. TCA activity leads to release of 14CO2 from either the 1-14C or 6-14C position of glucose, while OPPC activity causes release of 14CO2 only from the 1-14C position. Thus, OPPC activity was calculated using parallel vials and subtracting 14CO2 produced in the presence of 6-14C glucose from the 14CO2 produced in the presence of 1-14C glucose (Figure 1). Because of the use of radioactivity and the specificity of CO2 capture, this method is extremely sensitive (nmol range) and specific. It has the additional advantage that the “background” activity due to the TCA cycle is very low compared to that due to the OPPC (see Table 1).

  • OPPC activity = (14CO2 from 1-14C glucose) – (14CO2 from 6-14C glucose)

Figure 1.

Figure 1

Production of CO2 from Glucose by the OPPC and the TCA cycle. The OPPC releases CO2 from C1 of glucose, whereas the TCA cycle releases CO2 symmetrically from C1 and C6 after glucose is split by glycolysis. The OPPC produces 2 molecules of NADPH per molecule of CO2 released and ribose-5-phosphate. Ribose-5-phosphate can be further metabolized by the non-oxidative pentose cycle (NOPC). OPPC activity was calculated by subtracting the amount of 14CO2 released when cells were incubated with 6-14C-labeled glucose (TCA cycle activity) from the amount of 14CO2 released when cells were incubated with 1-14C-labeled glucose (i.e. OPPC + TCA cycle activity).

Table 1.

Effect of 1400W on RAW 264.7 NOx Production, OPPC activity, and TCA activity.

%pO2 0.07 0.07 2 2 50 50
1400W + + +
NOx NS 1.5 ± 2.1 ND 0.1 ± 1.1 ND 0.2 ± 0.3 ND
Nmol/106 cells S 4.9 ± 3.0 * 0.0 ± 0.5 15.5 ± 2.8 * ND 26.4 ± 1.5 * 0.3 ± 1.3
OPPC NS 14.7 ± 3.8 10.7 ± 1.7 7.4 ± 0.9 5.0 ± 1.9 25.1 ± 7.9 9.7 ± 1.0 §
Nmol CO2/106 cells S 25.0 ± 2.2 a 13.1 ± 0.4 b 59.0 ± 4.8 a 18.8 ± 1.9 a,b 71.8 ± 7.3 a 27.9 ± 5.3 a,b
TCA NS 0.3 ± 0.1 0.2 ± 0.02 1.7 ± 0.4 4.9 ± 0.4 c 4.1 ± 2.9 5.78 ± 2.9
Nmol CO2/106 cells S 0.4 ± 0.1 0.3 ± 0.01 0.6 ± 0.04 0.3 ± 0.04 d 0.6 ± 0.04 d 0.3 ± 0.1 d

RAW 264.7 cells were stimulated (S), or not (NS), with 1 µg/mL LPS and 100 U/mL IFNγ prior to exposure to 4 hours of 0.07%, 2%, or 10% O2 with ‘Thin Film’ cell culture. RAW 264.7 cells were treated with 100 µM 1400W (+), or not (−), for 1½ hours prior to ‘Thin Film’ cell culture. (ND) = not determined.

*

Effect of LPS and IFNγ treatment on media NOx (0.07% p < 0.05; 2% and 50% p < 0.001).

Effect of 1400W treatment on media NOx (0.07% p < 0.01, 50% p < 0.001).

Effect of pO2 on RAW 264.7 OPPC activity (0.07% and 50% > 2%, p < 0.05).

§

Effect of 1400W treatment on RAW 264.7 cells OPPC activity (p < 0.001).

a

Effect of LPS and IFNγ treatment on OPPC activity (p < 0.001).

b

Effect of 1400W treatment on OPPC activity by LPS and IFNγ stimulated RAW 264.7 cells (p < 0.001).

c

Effect of 1400W on TCA activity (p < 0.05).

d

Effect of LPS and IFNγ treatment on TCA activity (Without 1400W p < 0.01, With 1400W p < 0.001). Data presented are mean ± SD. (NOx n ≥ 3, OPPC n ≥ 4, TCA n ≥ 2).

Statistics

The apparent Km and Vmax values were calculated by SigmaPlot Enzyme Kinetics Module 1.1 using a Michaelis-Menten non-linear analysis. Comparison of means was tested by ANOVA for the effect of pO2 on measured values, and by two way ANOVA for the effect of pO2 and treatment on measured values. Data presented are mean ± SD.

RESULTS

Control of Cellular pO2

Cellular pO2 was regulated using a modified version of the ‘Thin Film’ culture method developed in our laboratory (39). To ensure that the modified method (i.e. glass vials with rubber stopper and needle) provided the same pO2 at the cellular level, we compared the cellular pO2 in glass dishes with the cellular pO2 in glass vials via the measurement of EF5 protein adducts (Figure 2). The formation of EF5-protein adducts increases as the pO2 decreases in a quantitative manner, thus permitting an accurate measurement of cellular pO2 because the pO2 is constant between the gas and liquid phases (39). The pO2 dependence of EF5 binding for RAW 264.7 cells incubated on glass dishes was similar to results from other cultured cell lines (42). Importantly, the EF5 binding for cells in glass vials closely paralleled EF5 binding for cells on glass dishes (Figure 2).

Figure 2.

Figure 2

EF5 binding in Glass Dishes versus Vials. RAW 264.7 cells were cultured for 3 hours in the presence of 100 µM EF5 at 0.03%, 0.14%, 0.21%, 0.59%, 1.04%, 1.91%, or 11.7% O2. RAW 264.7 cells were labeled with an EF5-specific Cy5 antibody and EF5 binding was measured by flow cytometry of a single cell suspension. Results across experiments were normalized to a positive control. Note that in the experiments presented, pO2 is defined as the % of oxygen in 1 atmosphere of dry gas at 37°C (ie. 100% = 760 mm of Hg).

pO2 dependence of NOx production

NOx, iNOS protein levels, and iNOS dimerization were measured after 4 hours of ‘Thin Film’ cell culture with the low glucose media required for the OPPC measurements. The results obtained in low glucose media were similar to previous cell culture systems (Figure 3 and references (4, 6)). Cumulative NOx released into the media by LPS and IFNγ-stimulated RAW 264.7 cells fit a Michaelis-Menten kinetic model with KmO2 of 0.66 ± 0.12 % (5 ± 1 Torr) and a Vmax of 25.2 ± 1.0 nmol/106 cells over 4 hours (R2 = 0.91, Figure 3A). NOx measured in lysates of LPS and IFNγ-stimulated RAW 264.7 cells exposed to 50% O2 for 4 hours was 3.5 ± 1.1 nmol/106 cells (i.e. about 13% of NOx detected in the media), suggesting the majority of NOx produced were released into the media. In the absence of LPS and IFNγ stimulation, RAW 264.7 cells did not produce detectable NOx (data not shown). pO2 did not alter iNOS protein concentration (Figure 3B) or iNOS dimerization (Figure 3C). Stimulation of RAW 264.7 cells with LPS and IFNγ decreased total protein isolated from the vials by 30%, consistent with previous reports (6, 43). pO2 alone did not affect cell adhesion as visualized by light microscopy, or the amount of total protein isolated from the vials (data not shown).

Figure 3.

Figure 3

NOx production, iNOS protein concentration, and iNOS dimerization in LPS and IFNγ stimulated RAW 264.7 cells cultured with ‘Thin Film’ cell culture. LPS and IFNγ stimulated RAW 264.7 cells were exposed to 0.07%, 0.13%, 0.24%, 0.61%, 2%, 10%, or 50% O2 (balance N2) for 4 hours using ‘Thin Film’ cell culture. A. Media NOx were converted to NO via reaction with vanadium chloride and measured with a Sievers Nitric Oxide Analyzer (see Methods). Data presented are mean ± SD. (n ≥ 3). B, C. Representative Western blots of an SDS-PAGE gel (B) and a low temperature SDS-PAGE gel (C) for iNOS and β actin. (n ≥ 3). (R) RAW 264.7 cells grown in atmospheric O2. (+) RAW 264.7 cells treated with LPS and IFNγ for at least 18 hours prior to exposure to the designated pO2. (−) RAW 264.7 cells not treated with LPS and IFNγ. (M) BioRad Kaleidoscope Prestained Standards (BioRad, Hercules CA).

pO2 dependence of OPPC Activity

Unstimulated RAW 264.7 OPPC activity exhibited a biphasic response to pO2 (Figure 4A), with a decrease between 0.07% and 2% O2 and a 2.5 fold increase between 10% and 50% O2. Stimulation of RAW 264.7 cells with LPS and IFNγ for 18 hours significantly increased OPPC activity at all pO2 (p < 0.001). OPPC activity correlated linearly with NOx production for pO2 greater than 0.13% O2 in LPS and IFNγ stimulated cells (Figure 4B). Treatment of LPS and IFNγ stimulated RAW 264.7 cells with 1400W, an iNOS inhibitor, completely inhibited NOx production (Table 1), and OPPC activity decreased close to levels observed without LPS and IFNγ treatment (p < 0.001; Figure 4A, Table 1). 1400W also decreased OPPC activity in unstimulated RAW 264.7 cells (Table 1) and unstimulated RAW 264.7 cells treated with PIMO (data not shown) at 50% O2, but not 2% and 0.07% O2, suggesting possible nonspecific effects of the inhibitor at 50% O2. Treatment of RAW 264.7 cells with LPS and IFNγ decreased TCA activity (Table 1), consistent with NOx-mediated respiratory inhibition (reviewed by (44)). Treatment with 1400W did not reverse the observed effect on TCA activity at any pO2 (Table 1).

Figure 4.

Figure 4

Correlation between OPPC activity and NOx production. A. RAW 264.7 cells (closed circles), LPS and IFNγ stimulated RAW 264.7 cells (open circles), or LPS and IFNγ stimulated RAW 264.7 cells pretreated with the iNOS inhibitor, 1400W at 100 µM (open triangles) were incubated with 1-14C glucose or 6-14C glucose in parallel experiments at 0.07%, 0.13%, 0.24%, 0.61%, 2%, 10%, or 50% O2 (balance N2). Cumulative OPPC activity was calculated by subtracting 14CO2 produced in the presence of 6-14C glucose (TCA Activity) from 14CO2 produced in the presence of 1-14C glucose (OPPC Activity + TCA Activity). OPPC activity by LPS and IFNγ stimulated RAW 264.7 cells was significantly different from RAW 264.7 cells and LPS and IFNγ stimulated RAW 264.7 cells + 1400W at all pO2 (p < 0.001). At this concentration (100 µM), 1400W did not completely inhibit the enhanced OPPC activity resulting from LPS and IFNγ stimulation. Data presented are mean ± SD. (n ≥ 4) B. Linear regression of OPPC activity and NOx production (data shown in Figure 2). y = [b1]x + [b0]

OPPC Challenge with HEDS and PIMO

To further increase oxidative challenge, RAW 264.7 cells were treated with HEDS or PIMO, two chemical oxidants, which operate by distinct mechanisms. Both treatments significantly increased OPPC activity in RAW 264.7 cells at 0.07% O2 and 50% O2 (p < 0.001, Figure 5). Stimulation of RAW 264.7 cells with LPS and IFNγ did not alter the magnitude of the increase in OPPC activity induced by HEDS or PIMO treatment. NOx production was measured during OPPC challenge to determine whether NO production was maintained despite the additional chemical oxidant stress (i.e. to assess whether the OPPC was able to accommodate both processes). NOx production by LPS and IFNγ stimulated RAW 264.7 cells was not affected by HEDS treatment at 0.07% O2 or 50% O2 (Figure 6). PIMO, a nitroimidazole, was detected by the nitric oxide analyzer (2 mM PIMO in media generated the equivalent signal of 3.6 µM NaNO2). Even after correcting for this signal, however, NOx measurements were significantly increased in PIMO treated LPS and IFNγ stimulated RAW 264.7 cells at 0.07% O2 (p < 0.05) and 50% O2 (p < 0.001), suggesting that some metabolites of PIMO might be detected as nitrite, nitrate, or nitrosothiols (45).

Figure 5.

Figure 5

OPPC Challenge with HEDS and PIMO. OPPC activity of RAW 264.7 cells and LPS and IFNγ stimulated RAW 264.7 cells was measured during treatment with one of two chemical oxidants, HEDS (2 mM) or PIMO (2 mM), at 0.07% and 50% O2 for 4 hours. (*) Significant effect of HEDS or PIMO treatment on OPPC activity versus no treatment (p < 0.001). Data presented are mean ± SD. (n = 4)

Figure 6.

Figure 6

NOx production during OPPC challenge with HEDS and PIMO. RAW 264.7 cells and LPS and IFNγ stimulated RAW 264.7 cells were treated with 2 mM HEDS or 2 mM PIMO during a 4 hour exposure to 0.07% or 50% O2. Media NOx were converted to NO via reaction with vanadium chloride and measured with a Sievers Nitric Oxide Analyzer. PIMO data were corrected for the signal of PIMO in media (3.64 nmol). A statistically significant effect of HEDS or PIMO on NOx versus no treatment was calculated where indicated (* p < 0.05, ** p < 0.001). Data presented are mean ± SD. (n ≥3).

DISCUSSION

Increased NOx production and increased OPPC activity were observed over a wide range of pO2 (0.07% to 50% O2) in LPS and IFNγ stimulated RAW 264.7 cells, consistent with previous reports of a relationship between NO production and NADPH oxidation in atmospheric O2 (1825). Moreover, inhibition of NO production decreased OPPC activity to near background levels at all pO2 investigated, suggesting that the majority of the increased OPPC activity observed in stimulated RAW 264.7 cells was directly related to NO and/or reactive nitrogen species production. Hypoxia did not inhibit the ability of the OPPC to respond to additional chemically mediated oxidative stress induced by HEDS or PIMO, and neither compound appeared to inhibit NOx production in stimulated cells. These results demonstrate that OPPC activity is not limiting for NO production by stimulated RAW 264.7 cells irrespective of pO2.

The pO2 dependence of NOx production was well fit by a Michaelis-Menten model, and the measured KmO2 (0.66% or 5 Torr) was within the range reported previously (46, 4648). The KmO2 is most consistent with our previous results using forced convection cell culture (22 Torr) (6), and our previous data from cell monolayers grown in dishes for 18 hours, after correction for iNOS activity and media depth (14 Torr) (4). The data are also consistent with measurements made by Rengasamy and Johns using RAW 264.7 cell lysates as the enzyme source in a steady state system (5 Torr) (48). Higher values have been reported using rapid equilibrium kinetics and recombinant iNOS (93 Torr (46) and 96 Torr (47)). The reasons underlying the higher apparent KmO2 measured with recombinant iNOS by rapid equilibrium kinetics are unknown, but may be due to inhibition of iNOS by NO feedback in the absence of the cellular milieu (47, 50). In any case, all of these apparent KmO2 values are within or just above the range of pO2 found in vivo (5 to 71 Torr (715)), indicating that tissue pO2 has the potential to significantly and rapidly affect NO production, as suggested previously (46, 4648).

The pO2 dependence of NOx production was not due to changes in iNOS protein levels or iNOS dimerization, consistent with our previous studies of short-term hypoxia (40 minutes) (6). Multiple studies have documented the affects of long-term (18 to 24 hours) hypoxia on iNOS upregulation via HIF 1α (4951). Increased expression of iNOS protein due to concomitant exposure to LPS, IFNγ, and hypoxia, however, is reported to require incubations greater than or equal to 6 hours (52). The half-life of iNOS in atmospheric O2 is approximately 1.6 hours (53), but the effect of hypoxia on the stability of the protein has not been investigated. In the present study, short-term hypoxia (i.e. < 4 hours) appeared to have negligible effects on the balance between transcription, translation, assembly, and degradation of iNOS.

Several previous studies have investigated the effects of short term hypoxia on NADPH and/or OPPC activity (3034), but we have found no prior studies that examined the pO2 dependence of OPPC activity in macrophages. Interestingly, OPPC activity in unstimulated RAW 264.7 cells exhibited a biphasic pO2 dependence in contrast to our previous work in HT1080 (human fibrosarcoma) and A549 (human lung carcinoma) cells (31). One potential source of NADP+ under hypoxia is the mitochondrial transhydrogenase. The decrease in mitochondrial respiration observed under severe hypoxia results in elevated glycolytic flux in order to maintain [ATP]. Hypoxic glycolysis produces lactate and NAD+. Mitochondrial transhydrogenase couples the reduction of NAD+ to the oxidation of NADPH (54). This reaction has been shown to increase under anaerobic conditions (55). We propose that the NADP+ produced by the mitochondrial transhydrogenase catalyzed reaction resulted in the stimulation of OPPC activity that we observed under hypoxia. While we are examining this hypothesis more thoroughly, it is important to note that the increase of OPPC activity between 2% and 0.07% for unstimulated RAW 264.7 cells under hypoxia, though statistically significant, is relatively small compared to the increase observed between 10% and 50% O2, and both changes are much smaller than the increase observed after LPS and IFNγ stimulation.

Stimulation of RAW 264.7 cells with LPS and IFNγ significantly increased OPPC activity at all pO2, thus extending previous reports for PAMPs stimulated macrophages in atmospheric O2 (2729, 56). These results are consistent with our results previously obtained in tumor cells (31), and conform with the classical view of decreased metabolic flux through the OPPC under hypoxia (30, 32, 33), whereby removal of O2 leads to a reducing environment. For example, Scholz et al. measured an increase in NADPH fluorescence in rat liver within seconds of exposure to near anoxic pO2, and measured a new steady state within minutes (30). Treatment with the iNOS inhibitor, 1400W, significantly reversed the affect of LPS and IFNγ stimulation at all pO2, suggesting the increase in OPPC activity was to accommodate NO production and/or the neutralization of reactive nitrogen mediated stress. Although NADPH may also be consumed by NADPH oxidase (57), or even by iNOS to produce superoxide (58), superoxide release by LPS and IFNγ stimulated RAW 264.7 cells is reported to only occur within the first hour after stimulation (59), and to be only 6 % of the magnitude of NO production (60, 61).

As seen in Fig. 4B, OPPC activity correlated linearly with NOx production above 0.13% O2, and roughly 2 molecules of CO2 were produced for each measured molecule of NOx. Since 2 molecules of NADPH are produced for every CO2 molecule released, this suggests a stoichiometry of 4 molecules NADPH per molecule of NOx. Theoretically, only 1 molecule of NADPH is required in the NO synthase reaction, but direct measurements have suggested the requirement of approximately 1.5 molecules of NADPH per NO molecule (reviewed by (58)). One possibility for this excess is that additional NADPH is required to maintain cellular redox equilibrium in the presence of reactive nitrogen and oxygen mediated stress (reviewed by (62, 63)). Our measurements suggest an even higher requirement, and another possibility for this arises from a limitation associated with our measurements: first, NOx does not account for all NO metabolites. Second, NO released into the gas phase of the vial was not measured. Since the 'Thin Film' culture system is designed to keep the gas phase in equilibrium with the liquid phase, it is not technically possible to confine NO to the media. Because NO production was not measured via radiolabeled L-arginine, it is impossible to calculate the amount of NO released into the gas phase. Therefore, the absolute relationship between NO, NOx production, and NADPH consumption remains to be addressed by additional studies.

Because OPPC activity decreased with pO2, we investigated whether OPPC activity was limited by hypoxia. HEDS and PIMO are chemical oxidants that induce oxidative stress by mechanisms that are not dependent on pO2 (17, 3638). Thus, these compounds were used to challenge the OPPC in RAW 264.7 cells under hypoxia. Treatment with HEDS or PIMO significantly increased OPPC activity under all conditions tested including hypoxia. To further investigate the relationship between OPPC activity and NOx production, we measured NOx production in LPS and IFNγ stimulated RAW 264.7 cells exposed to HEDS, and found that NOx production was maintained despite this chemical challenge to the OPPC. Therefore, we conclude that OPPC activity is not limiting for NO production in stimulated RAW 264.7 cells.

In summary, OPPC activity was increased following stimulation with LPS and IFNγ at all pO2 investigated in RAW 264.7 macrophages, a response which appears to be a direct consequence of NO production. OPPC activity under conditions of chemically mediated oxidative stress (i.e. HEDS or PIMO treatment) was not limited by hypoxia, nor was it limiting for NO production under any of the conditions investigated. Finally, we conclude that O2 substrate limitation is the primary mechanism responsible for decreased NO production by LPS and IFNγ stimulated macrophages exposed to acute hypoxia.

ACKNOWLEDGEMENTS

This work was supported by two grants from the National Institutes of Health (NIH CA92108 and NIH T32 CA009677-17), and by an award from the American Heart Association (AHA 0515359U).

LIST OF ABBREVIATIONS

G6PD

Glucose 6 phosphate dehydrogenase

HEDS

Hydroxyetheldisulfide

IFNγ

Interferon gamma

iNOS

Inducible nitric oxide synthase

LPS

Lipopolysaccharide

NOx

Nitric oxide metabolites

OPPC

Oxidative pentose phosphate cycle

PAMPS

Pathogen associated molecular patterns

PIMO

Pimonidazole

pO2

Partial pressure of O2

Footnotes

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

  • 1.Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2(10):907–916. doi: 10.1038/ni1001-907. [DOI] [PubMed] [Google Scholar]
  • 2.MacMicking J, Xie Q-w, Nathan C. Nitric oxide and macrophage function. Ann Rev Immunol. 1997;15(1):323–350. doi: 10.1146/annurev.immunol.15.1.323. [DOI] [PubMed] [Google Scholar]
  • 3.Stuehr D, Cho H, Kwon N, Weise M, Nathan C. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA. 1991;88:7773–7777. doi: 10.1073/pnas.88.17.7773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Otto CM, Baumgardner JE. Effect of culture pO2 on macrophage (RAW 264.7) nitric oxide production. Am J Physiol Cell Physiol. 2001;280(2):C280–C287. doi: 10.1152/ajpcell.2001.280.2.C280. [DOI] [PubMed] [Google Scholar]
  • 5.McCormick CC, Li WP, Calero M. Oxygen tension limits nitric oxide synthesis by activated macrophages. Biochem J. 2000;350:709–716. [PMC free article] [PubMed] [Google Scholar]
  • 6.Robinson MA, Baumgardner JE, Good VP, Otto CM. Physiological and hypoxic O2 tensions rapidly regulate NO production by stimulated macrophages. Am J Physiol Cell Physiol. 2008;294(4):C1079–C1087. doi: 10.1152/ajpcell.00469.2007. [DOI] [PubMed] [Google Scholar]
  • 7.Wilson DF, Lee WMF, Makonnen S, Finikova O, Apreleva S, Vinogradov SA. Oxygen pressures in the interstitial space and their relationship to those in the blood plasma in resting skeletal muscle. J Appl Physiol. 2006;101(6):1648–1656. doi: 10.1152/japplphysiol.00394.2006. [DOI] [PubMed] [Google Scholar]
  • 8.Braun RD, Lanzen JL, Snyder SA, Dewhirst MW. Comparison of tumor and normal tissue oxygen tension measurements using oxylite or microelectrodes in rodents. Am J Physiol Heart Circ Physiol. 2001;280(6):H2533–H2544. doi: 10.1152/ajpheart.2001.280.6.H2533. [DOI] [PubMed] [Google Scholar]
  • 9.Baumgartl H, Zimelka W, Lubbers D. Evaluation of pO2 profiles to describe the oxygen pressure field within the tissue. Comp Biochem Physiol A Mol Integr Physiol. 2002;132:75–85. doi: 10.1016/s1095-6433(01)00532-3. [DOI] [PubMed] [Google Scholar]
  • 10.Buerk DG, Nair P. PTIO2 and CMRO2 changes in cortex and hippocampus of aging gerbil brain. J Appl Physiol. 1993;74(4):1723–1728. doi: 10.1152/jappl.1993.74.4.1723. [DOI] [PubMed] [Google Scholar]
  • 11.Jiang J, Nakashima T, Liu KJ, Goda F, Shima T, Swartz HM. Measurement of pO2 in liver using EPR oximetry. J Appl Physiol. 1996;80(2):552–558. doi: 10.1152/jappl.1996.80.2.552. [DOI] [PubMed] [Google Scholar]
  • 12.Kaufman DL, Mitchell JA. Intrauterine oxygen tension during the oestrous cycle in the hamster: Patterns of change. Comp Biochem Physiol A Mol Integr Physiol. 1994;107(4):673–678. doi: 10.1016/0300-9629(94)90368-9. [DOI] [PubMed] [Google Scholar]
  • 13.Vanderkooi JM, Erecinska M, Silver LA. Oxygen in mammalian tissue: Methods of measurement and affinities of various reactions. Am J Physiol Cell Physiol. 1991;260(6):C1131–C1150. doi: 10.1152/ajpcell.1991.260.6.C1131. [DOI] [PubMed] [Google Scholar]
  • 14.James PE, Thomas MP, Jackson SK. Tissue oxygenation in sepsis; new insights from in vivo EPR. NMR Biomed. 2004;17(5):319–326. doi: 10.1002/nbm.910. [DOI] [PubMed] [Google Scholar]
  • 15.Foster GE, Poulin MJ, Hanly PJ. Intermittent hypoxia and vascular function: Implications for obstructive sleep apnoea. Exp Physiol. 2007;92(1):51–65. doi: 10.1113/expphysiol.2006.035204. [DOI] [PubMed] [Google Scholar]
  • 16.Eggleston LV, Krebs HA. Regulation of the pentose phosphate cycle. Biochem J. 1974;138:425–435. doi: 10.1042/bj1380425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Varnes M, Turtle SW, Biaglow JE. Nitroheterocyclic metabolism in mammalian cells: Stimulation of hexose monophosphate shunt. Biochem Pharmacol. 1984;33:1671–1677. doi: 10.1016/0006-2952(84)90290-9. [DOI] [PubMed] [Google Scholar]
  • 18.Leopold JA, Cap A, Scribner AW, Stanton RC, Loscalzo J. Glucoses-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J. 2001;15(10):1771–1773. doi: 10.1096/fj.00-0893fje. [DOI] [PubMed] [Google Scholar]
  • 19.Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton RC, Pitt B, Loscalzo J. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med. 2007;13(2):189–197. doi: 10.1038/nm1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Leopold JA, Zhang Y-Y, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol. 2003;23(3):411–417. doi: 10.1161/01.ATV.0000056744.26901.BA. [DOI] [PubMed] [Google Scholar]
  • 21.Guo L, Zhang Z, Green K, Stanton RC. Suppression of interleukin-1β-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase. Biochemistry. 2002;41(50):14726–14733. doi: 10.1021/bi026110v. [DOI] [PubMed] [Google Scholar]
  • 22.Hothersall JS, Gordge M, Noronha-Dutra AA. Inhibition of NADPH supply by 6-aminonicotinamide: Effect on glutathione, nitric oxide and superoxide in J774 cells. FEBS Lett. 1998;434(1–2):97–100. doi: 10.1016/s0014-5793(98)00959-4. [DOI] [PubMed] [Google Scholar]
  • 23.Tsai K-J, Hung I-J, Chow CK, Stern A, Chao SS, Chiu DTY. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett. 1998;436(3):411–414. doi: 10.1016/s0014-5793(98)01174-0. [DOI] [PubMed] [Google Scholar]
  • 24.Mei JJM, Hursting SD, Perkins SN, Phang JM. P53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages. Cancer Lett. 1998;129(2):191–197. doi: 10.1016/s0304-3835(98)00102-5. [DOI] [PubMed] [Google Scholar]
  • 25.Corraliza IM, Campo ML, Fuentes JM, Camposportuguez S, Soler G. Parallel induction of nitric oxide and glucose-6-phosphate dehydrogenase in activated bone marrow derived macrophages. Biochem Biophy Res Commun. 1993;196(1):342–347. doi: 10.1006/bbrc.1993.2254. [DOI] [PubMed] [Google Scholar]
  • 26.Mateo RB, Reichner JS, Mastrofrancesco B, Kraft-Stolar D, Albina JE. Impact of nitric oxide on macrophage glucose metabolism and glyceraldehyde-3-phosphate dehydrogenase activity. Am J Physiol Cell Physiol. 1995;268(3):C669–C675. doi: 10.1152/ajpcell.1995.268.3.C669. [DOI] [PubMed] [Google Scholar]
  • 27.Lazdins JK, Kuhner AL, David JR, Karnovsky ML. Alteration of some functional and metabolic characteristics of resident mouse peritoneal macrophages by lymphocyte mediators. J Exp Med. 1978;148(3):746–758. doi: 10.1084/jem.148.3.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Nathan CF, Karnovsky ML, David JR. Alterations of macrophage functions by mediators from lymphocytes. J Exp Med. 1971;133(6):1356–1376. doi: 10.1084/jem.133.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Costa Rosa LF, Curi R, Murphy C, Newsholme P. Effect of adrenaline and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic amp-dependent protein kinase mediated inhibition of glucose-6-phosphate dehydrogenase and activation of NADP+-dependent 'malic' enzyme. Biochem J. 1995;310(2):709–714. doi: 10.1042/bj3100709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Scholz R, Thurman RG, Williamson JR, Chance B, Bucher T. Flavin and pyridine nucleotide oxidation-reduction changes in perfused rat liver. I. Anoxia and subcellular localization of fluorescent flavoproteins. J Biol Chem. 1969;244(9):2317–2324. [PubMed] [Google Scholar]
  • 31.Turtle SW, Maity A, Oprysko PR, Kachur AV, Ayene IS, Biaglow JE, Koch CJ. Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: Implications for the mechanism of HIF-1 {alpha} stabilization under moderate hypoxia. J Biol Chem. 2007;282(51):36790–36796. doi: 10.1074/jbc.M700327200. [DOI] [PubMed] [Google Scholar]
  • 32.Kahraman S, Fiskum G. Anoxia-induced changes in pyridine nucleotide redox state in cortical neurons and astrocytes. Neurochem Res. 2007;32(4):799–806. doi: 10.1007/s11064-006-9206-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gupte SA, Okada T, McMurtry IF, Oka M. Role of pentose phosphate pathway-derived NADPH in hypoxic pulmonary vasoconstriction. Pulm Pharmacol Ther. 2006;19(4):303–309. doi: 10.1016/j.pupt.2005.08.002. [DOI] [PubMed] [Google Scholar]
  • 34.Gupte SA, Wolin MS. Hypoxia promotes relaxation of bovine coronary arteries through lowering cytosolic NADPH. Am J Physiol Heart Circ Physiol. 2006;290(6):H2228–H2238. doi: 10.1152/ajpheart.00615.2005. [DOI] [PubMed] [Google Scholar]
  • 35.Daniliuc S, Bitterman H, Rahat M, Kinarty A, Rosenzweig D, Nitza L. Hypoxia inactivates inducible nitric oxide synthase in mouse macrophages by disrupting its interaction with alpha-actinin-4. J Immunol. 2003;171:3225–3232. doi: 10.4049/jimmunol.171.6.3225. [DOI] [PubMed] [Google Scholar]
  • 36.Ayene IS, Biaglow JE, Kachur AV, Stamato TD, Koch CJ. Mutation in G6PD gene leads to loss of cellular control of protein glutathionylation: Mechanism and implication. J Cell Biochem. 2008;103(1):123–135. doi: 10.1002/jcb.21394. [DOI] [PubMed] [Google Scholar]
  • 37.Biaglow JE, Ayene IS, Turtle SW, Koch CJ, Donahue J, Mieyal JJ. Role of vicinal protein thiols in radiation and cytotoxic responses. Radiat Res. 2006;165(3):307–317. doi: 10.1667/rr3505.1. [DOI] [PubMed] [Google Scholar]
  • 38.Biaglow JE, Ayene IS, Koch CJ, Donahue J, Stamato TD, Mieyal JJ, Turtle SW. Radiation response of cells during altered protein thiol redox. Radiat Res. 2003;159(4):484–494. doi: 10.1667/0033-7587(2003)159[0484:rrocda]2.0.co;2. [DOI] [PubMed] [Google Scholar]
  • 39.Koch CJ. A 'Thin-Film' culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells. Radiat Res. 1984;97(2):434–442. [PubMed] [Google Scholar]
  • 40.Koch CJ. Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods Enzymol. 2002;352:3–31. doi: 10.1016/s0076-6879(02)52003-6. [DOI] [PubMed] [Google Scholar]
  • 41.Koch CJ, Stobbe CC, Bump EA. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: Quantitative differences found using the radiation sensitizing agent misonidazole or oxygen. Radiat Res. 1984;98(1):141–153. [PubMed] [Google Scholar]
  • 42.Koch CJ. Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole. Radiat Res. 2008;169(6):677–688. doi: 10.1667/RR1305.1. [DOI] [PubMed] [Google Scholar]
  • 43.Osawa Y, Lee HT, Hirschman CA, Xu D, Emala CW. Lipopolysacchardie-induced sensitization of adenylyl cyclase activity in murine macrophages. Am J Physiol Cell Physiol. 2006;290:C143–C151. doi: 10.1152/ajpcell.00171.2005. [DOI] [PubMed] [Google Scholar]
  • 44.Brown GC. Nitric oxide and mitochondria. Front Biosci. 2007;12:1024–1033. doi: 10.2741/2122. [DOI] [PubMed] [Google Scholar]
  • 45.McClelland RA, Panicucci R, Rauth AM. Electrophillic intermediate in the reactions of a 2-(hydroxylamino)imidazole. A model for biological effects of reduced nitroimidazoles. J Am Chem Soc. 1985;107:1762–1763. [Google Scholar]
  • 46.Abu-Soud HM, Ichimori K, Nakazawa H, Stuehr DJ. Regulation of inducible nitric oxide synthase by self-generated NO. Biochemistry. 2001;40(23):6876–6881. doi: 10.1021/bi010066m. [DOI] [PubMed] [Google Scholar]
  • 47.Dweik R, Laskowski D, Abu-Soud H, Kaneko F, Hutte R, Stuehr D, Erzurum S. Nitric oxide regulation in the lung: Regulation by oxygen through a kinetic mechanism. J Clin Invest. 1998;101:660–666. doi: 10.1172/JCI1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rengasamy A, Johns RA. Determination of Km for oxygen of nitric oxide synthase isoforms. J Pharmacol Exp Ther. 1996;276(1):30–33. [PubMed] [Google Scholar]
  • 49.Jung F, Palmer LA, Zhou N, Johns RA. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res. 2000;86:319–325. doi: 10.1161/01.res.86.3.319. [DOI] [PubMed] [Google Scholar]
  • 50.Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med. 1995;182:1683–1693. doi: 10.1084/jem.182.6.1683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Melillo G, Taylor L, Brooks A, Cox G, Varesio L. Regulation of inducible nitric oxide synthase expression in JFN-gamma- treated murine macrophages cultured under hypoxic conditions. J Immunol. 1996;157(6):2638–2644. [PubMed] [Google Scholar]
  • 52.Agorreta J, Garayoa M, Montuenga LM, Zulueta JJ. Effects of acute hypoxia and lipopolysaccharide on nitric oxide synthase-2 expression in acute lung injury. Am J Respir Crit Care Med. 2003;168:287–296. doi: 10.1164/rccm.200209-1027OC. [DOI] [PubMed] [Google Scholar]
  • 53.Kolodziej ski PJ, Koo J-S, Eissa NT. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. PNAS. 2004;101(52):18141–18146. doi: 10.1073/pnas.0406711102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kaplan NO, Swartz MN, Frech ME, Ciotti MM. Phosphorylative and nonphosphorylative pathways of electron transfer in rat liver mitochondria. Proc Natl Acad Sci. 1956;42(8):481–487. doi: 10.1073/pnas.42.8.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Stein AM, Kaplan NO, Ciotti MM. Pyridine nucleotide transhydrogenase. Vii. Determination of the reactions with coenzyme analogues in mammalian tissues. J Biol Chem. 1959;234(4):979–986. [PubMed] [Google Scholar]
  • 56.Nessel CC, Henry WL, Jr, Mastrofrancesco B, Reichner JS, Albina JE. Vestigial respiratory burst activity in wound macrophages. Am J Physiol Regul Integr Comp Physiol. 1999;276(6):R1587–R1594. doi: 10.1152/ajpregu.1999.276.6.R1587. [DOI] [PubMed] [Google Scholar]
  • 57.Lambeth JD. Nox enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4(3):181–189. doi: 10.1038/nri1312. [DOI] [PubMed] [Google Scholar]
  • 58.Stuehr DJ, Santolini J, Wang Z-Q, Wei C-C, Adak S. Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem. 2004;279(35):36167–36170. doi: 10.1074/jbc.R400017200. [DOI] [PubMed] [Google Scholar]
  • 59.Palazzolo-Ballance AM, Suquet C, Hurst JK. Pathways for intracellular generation of oxidants and tyrosine nitration by a macrophage cell line. Biochemistry. 2007;46(25):7536–7548. doi: 10.1021/bi700123s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Amatore C, Arbault S, Bouton C, Drapier JC, Ghandour H, Koh AC. Real-time amperometric analysis of reactive oxygen and nitrogen species released by single immunostimulated macrophages. Chem Bio Chem. 2008;9:1472–1480. doi: 10.1002/cbic.200700746. [DOI] [PubMed] [Google Scholar]
  • 61.Nalwaya N, Deen WM. Nitric oxide, oxygen, and superoxide formation and consumption in macrophage cultures. Chem Res Toxicol. 2005;18(3):486–493. doi: 10.1021/tx049879c. [DOI] [PubMed] [Google Scholar]
  • 62.Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239–247. doi: 10.1038/35041687. [DOI] [PubMed] [Google Scholar]
  • 63.Arteel GE, Briviba K, Sies H. Protection against peroxynitrite. FEBS Lett. 1999;445(2–3):226–230. doi: 10.1016/s0014-5793(99)00073-3. [DOI] [PubMed] [Google Scholar]

RESOURCES